Get the Stockscreener App
31.33
0.48%
0.15
After Hours:
31.33
Azenta Inc stock is traded at $31.33, with a volume of 751.93K.
It is up +0.48% in the last 24 hours and up +3.98% over the past month.
Azenta Inc provides biological and chemical sample exploration and management solutions, using precision automation and cryogenics to develop automated ultra-cold storage. It serves customers from research to commercialization with sample management, automated storage, genomic services, consumables, informatics, and repository services. The company operates through two segments: Sample Management Solutions, offering SRS and Core Products such as automated stores, cryogenic systems, sample tubes, consumables, instruments, and thawing devices, which generate majority of its revenue; and Multiomics, which provides genomic analysis services. The company operates in United States, China, United Kingdom, rest of Europe, and others, with majority of its revenue in the United States.
See More
Previous Close:
$31.18
Open:
$30.66
24h Volume:
751.93K
Relative Volume:
0.94
Market Cap:
$1.37B
Revenue:
$596.57M
Net Income/Loss:
$-109.88M
P/E Ratio:
-8.087
EPS:
-3.8741
Net Cash Flow:
$28.72M
1W Performance:
-4.92%
1M Performance:
+3.98%
6M Performance:
+24.67%
1Y Performance:
+6.13%
1-Day Range:
$30.61
$31.58
1-Week Range:
$30.57
$33.41
52-Week Range:
$15.93
$41.73
Azenta Inc Stock (AZTA) Company Profile
Name
Azenta Inc
Sector
Industry
Phone
(978) 262-2400
Address
200 SUMMIT DRIVE, BURLINGTON
Compare AZTA vs ISRG, BDX, ALC, RMD, MDLN
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AZTA
Azenta Inc
|
31.33 | 1.60B | 596.57M | -109.88M | 28.72M | -3.8741 |
ISRG
Intuitive Surgical Inc
|
366.70 | 132.30B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
184.74 | 51.11B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
70.50 | 35.25B | 10.63B | 819.00M | 1.59B | 1.6577 |
RMD
Resmed Inc
|
228.35 | 32.95B | 5.54B | 1.52B | 1.74B | 10.37 |
MDLN
Medline Inc
|
36.59 | 28.58B | 29.14B | 1.07B | 1.05B | 1.1956 |
Azenta Inc Stock (AZTA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-05-26 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-19-25 | Reiterated | Needham | Buy |
| Oct-30-25 | Upgrade | Jefferies | Hold → Buy |
| Aug-06-25 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Jul-22-25 | Resumed | Stephens | Equal-Weight |
| Dec-18-24 | Upgrade | Stephens | Equal-Weight → Overweight |
| Apr-04-24 | Initiated | Jefferies | Hold |
| Feb-01-24 | Reiterated | B. Riley Securities | Buy |
| Jul-19-23 | Initiated | Raymond James | Mkt Perform |
| May-10-23 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Feb-09-23 | Downgrade | Stephens | Overweight → Equal-Weight |
| Jan-03-23 | Downgrade | Evercore ISI | Outperform → In-line |
| Mar-31-22 | Resumed | B. Riley Securities | Buy |
| Mar-21-22 | Initiated | Evercore ISI | Outperform |
View All
Azenta Inc Stock (AZTA) Latest News
ETFs Investing in Azenta, Inc. Stocks - TradingView
Azenta (AZTA) Results Check: EPS Beats Its Estimate for the Current Session; Price Move: Shares Move Lower 1.79% in the Available RecordNew Analyst Coverage - vinanet.vn
Azenta, Inc.: Financial Data Forecasts Estimates and Expectations | BA3 | US1143401024 - marketscreener.com
Azenta: Needs To Overcome A Few Hurdles If The Rally Is To Continue (NASDAQ:AZTA) - Seeking Alpha
AZTA Q2 2026 Earnings: EPS Surpasses Estimates by 37.8% on Operational StrengthReturn On Equity - vinanet.vn
Azenta, Inc. (AZTA) Stock Forecasts - Yahoo Finance
Azenta Inc. (AZTA) Edges Higher to $33.53 as Life Sciences Tools Sector StabilizesExhaustion Gap - vinanet.vn
The 5 Most Interesting Analyst Questions From Azenta’s Q2 Earnings Call - Yahoo! Finance Canada
Azenta (AZTA) Is Up 11.5% After Returning To Profit And Raising Revenue OutlookHas The Bull Case Changed? - webull.com
Azenta (AZTA) SVP Pirogova has 1,085 shares withheld for tax obligations - Stock Titan
Azenta, Inc. Announces Appointment of Erik J. Bello as Chief Accounting Officer, Effective August 31, 2026 - marketscreener.com
Azenta, Inc. (AZTA) Stock Analysis: Navigating Growth in the Healthcare Sector with a 4.41% Potential Upside - DirectorsTalk Interviews
Weekly Recap: Azenta, Inc. Q3 revenue gain and analyst target raises - TradingView
Azenta Inc (AZTA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Securities Fraud Investigation Into Azenta, Inc. (AZTA) Continues - The National Law Review
Azenta Inc (AZTA) Stock News Today - TradingKey
Azenta, Inc. $AZTA Stake Cut by Quantinno Capital Management LP - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Is Investigating Azenta, Inc. (AZTA) And Encourages Investors to Connect - The National Law Review
Azenta (AZTA) Is Up 6.7% After Raising 2026 Guidance And Completing $50M Buyback – What’s Changed - Yahoo Finance
Multi-Manager Small Cap Equity Strategies Fund's Azenta Inc(AZTA) Holding History - GuruFocus
Azenta, Inc. 3Q 2026: Revenue $161.18M, EPS $0.05— 10-Q Summary - TradingView
Azenta (Nasdaq: AZTA) sells B Medical unit, books $149M impairment - Stock Titan
Life Science Funding Weakness Hit Azenta’s (AZTA) Outlook - Yahoo Finance
Azenta, Inc. $AZTA Shares Sold by Bank of New York Mellon Corp - MarketBeat
Arrowstreet Capital Limited Partnership Buys New Position in Azenta, Inc. $AZTA - MarketBeat
Azenta (AZTA) Drops 3%: Approaching Key Support at $29.33 Amid Sector HeadwindsIchimoku Entry - vinanet.vn
Azenta Inc (AZTA) (Q3 2026) Earnings Call Highlights: Organic Gr - GuruFocus
Azenta, Inc. Stock 12‑Month Price Target Raised to $33.8, Implies 12% Upside - TradingView
Azenta Inc (AZTA) (Q3 2026) Earnings Call Highlights: Organic Growth Surges 9% Amid Strategic ... - Yahoo Finance
Azenta Releases Q3 2026 Financial Results - AlphaStreet
Azenta (NASDAQ:AZTA) Price Target Raised to $37.00 - MarketBeat
Earnings call transcript: Azenta tops Q3 2026 estimates, shares edge higher - Investing.com
Transcript : Azenta, Inc., Q3 2026 Earnings Call, Aug 05, 2026 - marketscreener.com
Azenta Q3 Earnings Call Highlights - MarketBeat
Azenta, Inc. 2026 Q3ResultsEarnings Call Presentation (NASDAQ:AZTA) 2026-08-05 - Seeking Alpha
Azenta Inc. (BA3.SG) Q3 FY2026 earnings call transcript - Yahoo Finance
Sei Investments Co. Acquires 59,752 Shares of Azenta, Inc. $AZTA - MarketBeat
Azenta Inc (AZTA) (Q3 2026) Earnings Call Highlights: Organic Growth Surges 9% Amid Strategic ... By GuruFocus - Investing.com Canada
Is Azenta Inc (AZTA) a Value Play After Q3 Earnings Report? EPS at $(0.03), Revenue of $161MGF Score: 71/100 - GuruFocus
Azenta, Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Azenta (NASDAQ:AZTA) Issues Quarterly Earnings Results, Beats Estimates By $0.05 EPS - MarketBeat
Azenta, Inc. (AZTA) SVP acquires 335 shares via 2017 stock purchase plan - Stock Titan
Azenta (NASDAQ:AZTA) Reports Upbeat Q2 CY2026 - Yahoo Finance
Earnings Flash (AZTA) Azenta, Inc. Reports Q3 Revenue $161.2M, vs. FactSet Est of $149.3M - marketscreener.com
Earnings Flash (AZTA) Azenta, Inc. Posts Q3 Adjusted EPS $0.16 per Share - marketscreener.com
Earnings Flash (AZTA) Azenta, Inc. Posts Q3 Adjusted EPS $0.16 per Share, vs. FactSet Est of $0.11 - marketscreener.com
Azenta reports Q3 fiscal 2026: Revenue $161M, Adjusted EBITDA $18.5M, Non-GAAP EPS $0.16 - TradingView
Earnings Flash (AZTA) Azenta, Inc. Reports Q3 Revenue $161.2M, Vs. FactSet Est of $149.3M - Moomoo
Earnings Flash (AZTA) Azenta, Inc. Posts Q3 Adjusted EPS $0.16 per Share, Vs. FactSet Est of $0.11 - Moomoo
Azenta, Inc. Revised Earnings Guidance for the Full Year Fiscal Ending September 30, 2026 - marketscreener.com
Azenta earnings on deck: Can life sciences firm return to profit? - Investing.com
Azenta Inc Stock (AZTA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Azenta Inc Stock (AZTA) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Cornog William L | Director |
May 18 '26 |
Buy |
16.38 |
10,000 |
163,800 |
19,703 |
| Marotta John | President and CEO |
Sep 10 '25 |
Sale |
29.41 |
316 |
9,294 |
105,980 |
0.76%
1.02%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):